U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

Read also:

• Ominous 'Chamaeleon' is hiding a stellar secret: Space photo of the week - Live Science
• Is it true that LGB should drop T?
• What is your review of working in EY?
• Quantum embezzlement is hiding in known one-dimensional materials: Study - Interesting Engineering
• MIT chemical engineers make potentially game-changing breakthrough with crude oil: 'Creates a new way to apply it' - The Cool Down
• 'Strawberry moon' set to dazzle as rare lunar standstill graces the night sky - KOMO
• Does having the wrong address on my car insurance invalidate my policy?
• The Dogs of Chernobyl Are Experiencing Rapid Evolution, Study Suggests - MSN
• I Sampled All the Best Mushroom Gummies—Here’s What I Found - WIRED
• Republican Trump is a billionaire, president, won't be held accountable for multiple felonies, and pretty much has whatever he wants. So why is he always whining and crying about stupid, pointless stuff? Is he incapable of happiness?
• Why is Canada letting too many Indians in Canada?